Go Pro

AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$34.48 -0.31 (-0.89%)
As of 08/21/2026 03:58 PM Eastern

AMN vs. EYE, MEDP, VEEV, WST, and LFST

Should you buy AMN Healthcare Services stock or one of its competitors? AMN Healthcare Services's main competitors and comparable companies include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size.

How does AMN Healthcare Services compare to National Vision?

National Vision (NASDAQ:EYE) and AMN Healthcare Services (NYSE:AMN) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

99.2% of AMN Healthcare Services shares are held by institutional investors. 2.4% of National Vision shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, AMN Healthcare Services had 4 more articles in the media than National Vision. MarketBeat recorded 8 mentions for AMN Healthcare Services and 4 mentions for National Vision. National Vision's average media sentiment score of 1.45 beat AMN Healthcare Services' score of 0.82 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision currently has a consensus price target of $30.36, suggesting a potential upside of 69.82%. AMN Healthcare Services has a consensus price target of $31.43, suggesting a potential downside of 8.85%. Given National Vision's stronger consensus rating and higher possible upside, equities analysts plainly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

National Vision has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market.

AMN Healthcare Services has a net margin of 3.06% compared to National Vision's net margin of 2.47%. AMN Healthcare Services' return on equity of 19.92% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.47% 6.78% 3.01%
AMN Healthcare Services 3.06%19.92%5.93%

National Vision has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.71$29.60M$0.6129.31
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87

Summary

National Vision beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

Medpace (NASDAQ:MEDP) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

In the previous week, Medpace had 20 more articles in the media than AMN Healthcare Services. MarketBeat recorded 28 mentions for Medpace and 8 mentions for AMN Healthcare Services. Medpace's average media sentiment score of 1.10 beat AMN Healthcare Services' score of 0.82 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
21 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

Medpace currently has a consensus price target of $584.18, suggesting a potential downside of 5.89%. AMN Healthcare Services has a consensus price target of $31.43, suggesting a potential downside of 8.85%. Given Medpace's stronger consensus rating and higher probable upside, equities research analysts clearly believe Medpace is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

Medpace has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B6.85$451.12M$17.0636.39
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87

Medpace has a net margin of 17.67% compared to AMN Healthcare Services' net margin of 3.06%. Medpace's return on equity of 110.15% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace17.67% 110.15% 24.84%
AMN Healthcare Services 3.06%19.92%5.93%

78.0% of Medpace shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Medpace beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

Veeva Systems (NYSE:VEEV) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

Veeva Systems has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

Veeva Systems presently has a consensus target price of $255.58, suggesting a potential upside of 2.95%. AMN Healthcare Services has a consensus target price of $31.43, suggesting a potential downside of 8.85%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts plainly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veeva Systems
1 Sell rating(s)
8 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.64
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

Veeva Systems has a net margin of 28.37% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Veeva Systems28.37% 13.72% 11.31%
AMN Healthcare Services 3.06%19.92%5.93%

88.2% of Veeva Systems shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 10.6% of Veeva Systems shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veeva Systems$3.20B12.62$908.91M$5.6144.25
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87

In the previous week, Veeva Systems had 16 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Veeva Systems and 8 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 0.90 beat AMN Healthcare Services' score of 0.82 indicating that Veeva Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veeva Systems
12 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Veeva Systems beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

West Pharmaceutical Services has a net margin of 16.98% compared to AMN Healthcare Services' net margin of 3.06%. West Pharmaceutical Services' return on equity of 20.11% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.98% 20.11% 14.83%
AMN Healthcare Services 3.06%19.92%5.93%

West Pharmaceutical Services currently has a consensus price target of $368.08, indicating a potential upside of 4.29%. AMN Healthcare Services has a consensus price target of $31.43, indicating a potential downside of 8.85%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

In the previous week, West Pharmaceutical Services had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 15 mentions for West Pharmaceutical Services and 8 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 1.57 beat AMN Healthcare Services' score of 0.82 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
14 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
AMN Healthcare Services
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market.

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B8.08$493.70M$7.8145.19
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does AMN Healthcare Services compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

LifeStance Health Group currently has a consensus price target of $12.38, indicating a potential downside of 0.76%. AMN Healthcare Services has a consensus price target of $31.43, indicating a potential downside of 8.85%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe LifeStance Health Group is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

LifeStance Health Group has a net margin of 3.19% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group3.19% 3.39% 2.33%
AMN Healthcare Services 3.06%19.92%5.93%

LifeStance Health Group has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.40$9.66M$0.1395.92
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87

LifeStance Health Group has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

In the previous week, AMN Healthcare Services had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for AMN Healthcare Services and 7 mentions for LifeStance Health Group. AMN Healthcare Services' average media sentiment score of 0.82 beat LifeStance Health Group's score of 0.63 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LifeStance Health Group beats AMN Healthcare Services on 10 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.33B$9.83B$7.38B$24.31B
Dividend YieldN/A2.55%2.53%3.70%
P/E Ratio12.8734.38272.3330.23
Price / Sales0.495.00623.2921.01
Price / Cash4.15125.1278.6232.49
Price / Book1.804.0513.056.77
Net Income-$95.70M$311.06M$3.47B$1.07B
7 Day Performance0.04%0.83%2.10%-0.65%
1 Month Performance0.80%1.29%6.12%2.45%
1 Year Performance66.72%15.68%25.00%14.87%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
2.3153 of 5 stars
$34.48
-0.9%
$31.43
-8.8%
+75.3%$1.33B$2.73B12.872,664
EYE
National Vision
4.5607 of 5 stars
$18.47
-4.3%
$30.36
+64.4%
-25.6%$1.53B$1.99B30.2813,138
MEDP
Medpace
3.7072 of 5 stars
$597.12
+3.2%
$584.18
-2.2%
+36.9%$16.15B$2.53B35.006,200
VEEV
Veeva Systems
3.3419 of 5 stars
$238.40
-2.2%
$252.08
+5.7%
-12.1%$39.60B$3.20B42.507,928
WST
West Pharmaceutical Services
3.7919 of 5 stars
$346.69
-0.8%
$368.08
+6.2%
+45.6%$24.59B$3.07B44.3910,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners